Medical comms - Press Releases

Date	Title	Company
01-Nov-2019	New statistics show shockingly low awareness of pancreatic cancer: 74% of people cannot name a single symptom	Pancreatic Cancer Action
31-Oct-2019	OB-002 Significantly Reduces Bone Metastasis in a Murine Model of Breast Cancer	Orion Biotechnology Canada, Ltd
31-Oct-2019	Vertex Announces European Medicines Agency Marketing Authorization Application Validation for VX-445 (Elexacaftor), Tezacaftor and Ivacaftor Combination Treatment in Cystic Fibrosis	Vertex Pharmaceuticals
31-Oct-2019	RINVOQ™ (upadacitinib) Meets Primary and All Ranked Secondary Endpoints in Phase 3 Study in Psoriatic Arthritis	AbbVie
31-Oct-2019	The Alliance for Regenerative Medicine Outlines Recommendations for Increasing the Number of European-Based ATMP Clinical Trials	Alliance for Regenerative Medicine
31-Oct-2019	Aenitis Technologies and the Direction Générale de l'Armement (DGA) sign a partnership to develop a new AMSC-S project with a 1,2 million euros budget	AENITIS TECHNOLOGIES
31-Oct-2019	Biophytis Files Protocol Amendment to Optimize the SARA-INT Phase 2b Clinical Trial for Sarcopenia	Biophytis SA
31-Oct-2019	Bulletin from Moberg Pharma’s AGM on October 30th , 2019	Moberg Pharma
31-Oct-2019	Harley Street clinics to offer new brain stimulation treatment for depression	Flow Neuroscience
31-Oct-2019	First NHS patient receives Chiesi’s advanced-therapy-medicinal product, Holoclar▼ for moderate-to-severe limbal stem cell deficiency (LSCD) caused by chemical or thermal eye burns	Chiesi UK
31-Oct-2019	Investigational Ebola Vaccine from Janssen and Bavarian Nordic to Support Outbreak Response in Democratic Republic of the Congo	Bavarian Nordic A/S
30-Oct-2019	ProteoGenix Launches New Human and Rabbit Antibody Libraries to Speed Up the Discovery of Better Therapeutic and Analytical Antibodies	ProteoGenix
30-Oct-2019	Navigating the Globalisation of Clinical Trials	Medidata
30-Oct-2019	MultiTEP Platform-Based Epitope Vaccine Targeting the Phosphatase Activating Domain (PAD) of Tau Shows Clear Therapeutic Efficacy in PS19 Mice	Capo Therapeutics, Inc
30-Oct-2019	Sanifit announces that the Phase 2b CaLIPSO trial of SNF472 met its primary endpoint in slowing the progression of cardiovascular calcification in patients on hemodialysis Top line data to be presented at 2019 Scientific Sessions of American Heart Association	Sanifit
30-Oct-2019	Dupixent® (dupilumab) now approved in European Union for severe chronic rhinosinusitis with nasal polyposis	Regeneron
30-Oct-2019	Registration opens for SMi’s AI in Drug Discovery Conference 2020	SMi Group
29-Oct-2019	PharmiWeb To Launch In Australia	PharmiWeb.Jobs
29-Oct-2019	Upperton continues to invest in key equipment to support expansion of its solid dosage form capabilities and CDMO services	Upperton Pharma Solutions
29-Oct-2019	Sense Biodetection Raises £12.3m to Progress Instrument-Free Molecular Diagnostics	Sense Biodetection Limited